Search by Drug Name or NDC

    NDC 63868-0290-06 Severe Cold and Cough Daytime 650; 20; 10 mg/1; mg/1; mg/1 Details

    Severe Cold and Cough Daytime 650; 20; 10 mg/1; mg/1; mg/1

    Severe Cold and Cough Daytime is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Chain Drug Manufacturing Assn. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63868-0290
    Product ID 63868-290_3c291770-4524-474a-ad3f-4fc34416f754
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Severe Cold and Cough Daytime
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Chain Drug Manufacturing Assn
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 63868-0290-06 (63868029006)

    NDC Package Code 63868-290-06
    Billing NDC 63868029006
    Package 6 PACKET in 1 CARTON (63868-290-06) / 1 POWDER, FOR SOLUTION in 1 PACKET
    Marketing Start Date 2018-07-25
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 26d2d39a-6d37-45d9-a4f9-4015cc97158b Details

    Revised: 1/2022